KLRK1 and acute myeloid leukemia: NKG2D CAR-NK cells generated from primary human NK cells successfully eradicated AML cells both in vitro and in a preclinical KG-1 cell-line derived mouse model, with their persistence enhanced by IL-15 co-expression (32).